Navigation Links
Sinovac to Participate in Two Upcoming Investor Conferences
Date:10/29/2008

BEIJING, Oct. 29 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that it is scheduled to present at two upcoming investor conferences, including the Oppenheimer 19th Annual Healthcare Conference in New York City and the Credit Suisse Asian Healthcare Conference in Beijing, China.

Ms. Vanessa Wu, Senior Financial Manager, is scheduled to present on Tuesday, November 4, 2008 at 3:20 pm at Oppenheimer 19th Annual Healthcare Conference, at the Waldorf-Astoria Hotel in New York, NY.

Dr. Weidong Yin, Chairman, President and CEO, is scheduled to attend the Credit Suisse Asian Healthcare Conference on November 5 and 6, at The Westin Beijing Hotel at Financial Street in Beijing, China.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this pres
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
2. Sinovac Biotech Holds 2007 Annual General Meeting
3. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
4. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
5. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
6. Sinovac Adjourns Annual General Meeting
7. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
8. Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
9. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
10. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 The global ... billion in 2019. It is expected to grow ... 2019, and was valued at $1.8 billion in ... Transparency Market Research. , For more information regarding ... . , The research report, titled “Companion Diagnostics ...
(Date:8/29/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the six months ended June 30, ... Canadian dollars and presented under International Financial Reporting ... , Announced top-line results related to ... for subjects enrolled in the Phase 2 iDEAL ...
(Date:8/29/2014)... Due to a misstatement posted by the Family Resource ... Center, LLC ( ASCTC ) was reported as an entity ... benefit ALS patients. Because of ASCTC's exclusive focus on ... therapeutic applications, FRC listed ASCTC as one of several alternatives ... not to support research that requires the death of human ...
(Date:8/28/2014)... August 28, 2014 SPIE Fellow Glenn ... and Optical Science and Director of the Center for ... Carolina at Charlotte, and co-founder and Chairman of the ... as the 2015 Vice President of SPIE, the international ... Philip Stahl announced recent election results at the Annual ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... Systems will be announcing the availability of the ... in its retractable, wall-mounted WorkStations at the 2009 ... system simplifies and streamlines making user and lock ... new cost-effective locking system can be ordered with ...
... Spectrometry Technology Allows Contract Research Organization to Offer ... 16 /PRNewswire-FirstCall/ -- Waters ... that XenoTech (Lenexa, KS) has begun offering new ... its recent acquisition of a Waters(R) Synapt(TM) High ...
... Inc. (OTC Bulletin Board: YGYB; "Yongye" or the ... animal nutrient products located,in the People,s Republic of ... year ended December 31, 2008. , ... have not yet been reviewed by,its independent auditors, ...
Cached Biology Technology:Proximity Systems' LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations 2XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System 2XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System 3Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008 2Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008 3Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008 4
(Date:8/28/2014)... to Research Careers) Program has announced the travel ... Medicine,s Conference on Integrative Physiology of Exercise from ... awards are meant to promote the entry of ... into the mainstream of the basic science community ... at the American College of Sports Medicine,s Conference ...
(Date:8/28/2014)... will be built worldwide by 2050. Many of these ... bring an influx of destructive loggers, hunters and illegal ... a ,global roadmap, for prioritising road building across the ... development and environmental protection. , The map has two ... of ecosystems and a ,road-benefits, layer that estimates the ...
(Date:8/28/2014)... from Washington, Oregon, northern California, and Alaska totaled 515 ... of 2014, an increase of more than 10 percent ... Forest Service,s Pacific Northwest Research Station reported today. During ... 4 percent to 247 million board feet. , The ... than 5 percent to $390 million in the same ...
Breaking Biology News(10 mins):Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3West coast log exports up, lumber exports down in second quarter of 2014 2
... led by CSIRO,s Dr Kishore Prayaga has been awarded a ... a simple genetic test which has the potential to end ... is a routine practice carried out by beef producers to ... handlers. About half of Australia,s 21 million ...
... Pacific Northwest National Laboratory has developed a reusable organic liquid ... sulfur dioxide out of industrial emissions from power plants. The ... to capture double the amount of harmful gases in a ... "Power plants could easily retrofit to use our process ...
... with an increased risk of dying from any cause according ... PLoS Medicine. The study finds that the increased ... and 70 years of age with severe sleep-disordered breathing, and ... coronary heart disease in men. Sleep-disordered breathing is characterized ...
Cached Biology News:Breeding their horns off -- a winner 2Scrubbing sulfur 2Severe breathing disorders during sleep are associated with an increased risk of dying 2
... using a protein engineering approach that introduced amino ... wild-type DNase I. These changes markedly increase the ... is a versatile enzyme that has a 6-fold ... maintain at least 50% of peak activity in ...
Request Info...
Request Info...
... Ligase catalyzes the formation of a phosphodiester ... in nicked duplex DNA molecules or between ... complementary strand at 45 - 65?. Tfi ... much higher temperatures than conventional DNA ligases, ...
Biology Products: